
Where MedTech professionals gain clarity and confidence to navigate complex risk, quality, and leadership challenges.
| Platform | Pricing | Only free issues | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 551 | Founded | 3 years ago | Last Issue | 6 days ago |
| Active | |||||

In responding to Comment #29 in the preamble of the QMSR1, FDA addressed several terminology questions, including correction, corrective action, preventive action, and the definition of batch or lot.
One detail is easy to miss: FDA intende...
Dear colleagues:
Business teams naturally favor broad intended-use and indication statements. A wider population expands patient access and commercial opportunity, and positive clinical-trial results may appear to support that breadth.
Bu...
“When done well, HHE evolves from a procedural requirement into a strategic tool that reflects how your organization makes risk-based decisions.”
In this episode of the Let’s Talk Risk! conversation, host Naveen Agarwal speaks...
In responding to Comment #29 in the preamble of the QMSR1, FDA reminded manufacturers that corrective and preventive actions must be verified or validated to ensure they are effective and do not adversely affect the finished device.
This i...
Dear colleagues:
Many post-market surveillance systems are built to receive complaints, adverse events, service records, literature, and field reports. These inputs are essential, but they are largely reactive. They tell us what has alread...
Subscribers, engagement, traffic and sponsorship for Let's Talk Risk!.
| Subscribers | Engagement | 73 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #190 |
The writers behind this newsletter.
MedTech risk management advisor, educator, and creator of Let’s Talk Risk! Sharing ideas on risk, quality, leadership, and decision-making under uncertainty.
Jonathan is a human factors engineer and product designer specializing in medical devices. For 20+ years, he's helped teams improve device safety and usability while meeting international regulations. Currently Principal Consultant at Curiolis.
You can find recent issues that have been published by Let's Talk Risk! on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Let's Talk Risk!, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Let's Talk Risk! as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Let's Talk Risk! using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Let's Talk Risk!. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.